Related Experiment Videos
[Artificial trabeculum (MESH). Clinical and histological study in the rabbit]
P Helies1, J M Legeais, M Savoldelli
1Laboratoire Universitaire de Recherche en Ophtalmologie, Hôtel-Dieu, Paris.
Journal Francais D'Ophtalmologie
|October 6, 1998
Summary
The MESH implant, a novel device for glaucoma surgery, demonstrated effective intraocular pressure reduction and sustained filtration in rabbits over six months. This innovative technique shows promise for treating open-angle glaucoma with a simpler, less invasive approach.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Surgical Innovation
Context:
- Trabeculectomy often leads to postoperative hypotony, necessitating alternative filtration methods.
- The MESH implant, an expanded polytetrafluoroethylene (ePTFE) device, mimics the natural meshwork to ensure long-lasting filtration.
- Assessing novel glaucoma surgical devices is crucial for improving patient outcomes.
Purpose:
- To evaluate the tolerance, biocompatibility, and efficacy of the MESH implant over a 6-month period in a rabbit model.
- To compare the MESH implant's performance with and without adjunctive mitomycin C (MMC) or 5-fluorouracil (5-FU).
- To determine the potential of the MESH implant as a less invasive alternative to trabeculectomy for open-angle glaucoma.
Summary:
- The MESH implant facilitated filtering bleb formation within 3-6 weeks, with sustained aqueous humor drainage observed over 6 months.
- Histological analysis confirmed the MESH implant's biocompatibility, stable intrascleral integration, and ability to drain fluid, even with fibroblast colonization.
- The MESH implant effectively reduced intraocular pressure (IOP) in rabbits, with significant reductions noted in MESH-alone, MESH + 5-FU, and MESH + MMC groups.
Impact:
- The MESH implant offers a promising, less invasive surgical technique for managing open-angle glaucoma.
- This device has the potential to reduce complications associated with traditional glaucoma surgeries, such as hypotony.
- The study provides valuable preclinical data supporting the MESH implant's suitability for clinical application in glaucoma treatment.